Zydus Lifesciences is transitioning from a traditional pharmaceutical company to a more patient-driven organization. The company plans to f...

"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...

Consumer demand for protein in everyday staples is driving new product launches and supply deals. Food and beverage makers and cafe chains ...

Talk of tariffs, especially steep ones, makes the market nervous. Which is exactly why the next few trading sessions are critical, and why ...

Advent International will invest Rs 3,150 crore in Yatharth Hospitals for a significant stake. This marks one of the largest private equity...

As an investor, what you need to do at this point of time is this: A bit of extra work in terms of stock-picking so that you avoid anxiety ...

Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...

The Rs 550 crore public issue was priced at Rs 676 per share. The offering comprised a fresh issue of 11.83 lakh shares worth Rs 80 crore a...

Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...

Brookfield is negotiating to acquire PGP Glass from Blackstone for $1.3 billion. This deal marks a significant transaction between two majo...

In the stock market, when a big theme or sectoral trend takes off, most investors focus on the face of it. A brand with which they can rela...

Chinese President Xi Jinping's visit highlights India-China trade's stark imbalance. India's imports from China vastly exceed its exports, ...

Prasol Chemicals IPO enters its final bidding day with muted demand and zero GMP, pointing to expectations of a flat listing. The Rs 500 cr...

With the US market shedding weight overnight, the probability is high that Thursday will see another day of choppy trading. The best way to...

At the same time, the fund is evaluating hospital expansion, hybrid diagnostics businesses and valuations to identify healthcare companies ...

Prasol Chemicals plans an IPO to raise funds for debt repayment and expansion. The company's revenue and profits have shown significant gro...

Prasol Chemicals will launch its Rs 500-crore Initial Public Offering on September 8. The company has fixed the price band at Rs 643-676 pe...